VRTX $163.43 -2.74 (-1.65%)
Tue, Dec 18, 2018
Vertex Pharmaceuticals Inc is a Health Care stock that trades on the NASDAQ with a market cap of $24.07 Billion
Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several mid- and late-stage products targeting this market. Vertex successfully developed and commercialized two HIV protease inhibitors, which were outlicensed to GlaxoSmithKline. Vertex's pipeline also includes therapies for the treatment of cancer, pain, inflammatory diseases, influenza, and other rare diseases. http://www.vrtx.com
Vertex Pharmaceuticals Inc Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $173.68 which is 5.9% above the stock price of $163.43.
200 Day Moving Average
The 200 Day Moving Average is at 169.14 which is 3.38% abovethe stock price of $163.43.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
VRTX Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $163.43.
The Year To Date (YTD) return is +6.88%.
52 Week Low
The 52 Week Low stock price is $145.12 set on Wed, Dec 20, 2017 which is 364 days ago.
The current price per share is 12.62% above the 52 week low.
52 Week High
The 52 Week High stock price is $192.74 set on Fri, Sep 28, 2018 which is 82 days ago.
The current price per share is -15.21% below the 52 week high.
All Time High
The All Time High stock price is $192.74 set on Fri, Sep 28, 2018 which is 82 days ago.
The current price per share is -15.21% below the all time high.
VRTX Stock Split History
Vertex Pharmaceuticals Inc has had 1 stock splits.
|Split Date||Split Ratio|
|Thu, Aug 24, 2000||1 to 2|
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $0.51.
The Price To Earnings (P/E) Ratio is 67.75.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for Vertex Pharmaceuticals Inc was Wed, Jul 25, 2018.
Since this earnings release 147 days ago, the stock price is down by -6.55%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The most recent Earnings Release Date was on Wed, Oct 24, 2018, which was 56 days ago.
Since this earnings date, the stock price is down by -6.17%.
Vertex Pharmaceuticals Inc Dividend
Below is important Dividend information.
VRTX currently does not pay a dividend.
You may like this list of best dividend stocks of 2018.
Below are some other Biotech & Pharma industry stocks like Vertex Pharmaceuticals Inc.